Western Indiana Recovery Services

 

 An Opioid Treatment Program (OTP) of Hamilton Center Inc.

88 Wabash Court, Terre Haute, IN 47807

To schedule an appointment stop by the clinic, or call:

812-231-8484 or 833-232-0215

No referral needed. Illinois residents welcome.

Hours of Operation:

Monday – Friday 6:00am – 12:00pm

Saturday, Sunday, and Holidays 7:00am – 10:00am

Opioid use disorder is a complex problem. Individuals with this disorder were once thought to have a character defect or moral weakness; however, medical practitioners now consider opioid use disorder to be a long-term illness, like asthma, hypertension (elevated blood pressure), or diabetes.

Western Indiana Recovery Services, an opioid treatment program of Hamilton Center, Inc., is the first of its kind in the area. The clinic provides comprehensive treatment for adults (age 18 or older) who are struggling with opioid use disorder. The program provides daily medication (methadone) coupled with individual and group therapy and case management services to treat each patient’s unique needs.

Whether opioids are prescribed by a physician or acquired illegally, with continued use and misuse, they can cause serious changes to the brain and body. People often hesitate to begin the recovery process due to fear of the physical symptoms associated with withdrawal, or because they doubt recovery is even possible.

Western Indiana Recovery Services can provide help, hope, and recovery from the debilitating disease of opioid use disorder. People are able to regain their lives, heal their families, secure employment, significantly limit exposure to diseases like HIV and Hepatitis, and avoid criminal activity often associated with illegal drug use. Opioid use disorder is a disease; treatment is available; and recovery is possible.

What to Expect from a Typical First Appointment

(Approximate time 1.5 hours)*

*visits vary based on individual clinical needs

Services Offered

Medication Assisted Treatment (MAT): Methadone is a medication administered daily for opioid use disorder under monitored, controlled conditions in the clinic. Methadone has been utilized for years with a great deal of research determining its safety and effectiveness. Once patients begin taking methadone at appropriate doses, withdrawal is avoided, cravings are minimized, and physical and mental stabilization occurs.

Individual and Group Therapy: For the first year of treatment in the program, patients are required to attend individual and group therapy. Behavioral health services are critical to substance abuse treatment and assist patients in learning about issues such as the science behind addiction, relapse prevention, and how to manage cravings and related behaviors. Trained counselors function simultaneously as teachers and coaches, fostering a positive and encouraging relationship to reinforce behavior change and recovery.

Case Management Services: Case management focuses on assisting patients with connecting with their community to support their recovery. Counselors have broad knowledge of community resources and work to link patients to healthcare, insurance and other benefits, educational institutions, sober living facilities, support groups, housing, and other social service agencies. In addition, counselors may help to coordinate care with the patient’s physicians, referring agencies, and/or the court system.

Admission Criteria

Specific admission criteria has been developed for the program. Individuals must be at least 18 years of age, have misused opiates (heroin or prescription pain medication) for at least one year, and be in some form of active withdrawal.* All patients being admitted must present a State issued photo ID.

*Admission criteria may vary based on individual clinical needs

Fees

Fees are based on the provision of service. Rates are competitive. Indiana Medicaid is accepted. For those without insurance, there will be a one-time intake fee and a daily cost of $20.00.

History and Effectiveness of Methadone Maintenance Treatment

Methadone treatment provides the patient who is opioid dependent with medication, health, social, and rehabilitation services that relieve withdrawal symptoms, reduce physiological cravings, and allow normalization of the body’s functions. Methadone treatment has been available for over 30 years and has been confirmed effective for opioid dependence in numerous scientific studies.

Moreover, in 1997, the U.S. Department of Health and Human Services’ National Institutes of Health (NIH) Consensus Panel found the following concerning methadone treatment: “Of the various treatments available, methadone maintenance treatment, combined with attention to medical, psychiatric and socioeconomic issues, as well as drug counseling, has the highest probability of being effective.”

Methadone treatment programs are staffed by professionals with medical, clinical, and administrative expertise. Patients receive medication from a health professional. Patients routinely meet with a primary counselor (social worker, caseworker, or certified substance abuse counselor), attend clinic groups, and access medical and social services.

Methadone’s effectiveness, and the absence of any serious, long-term side effects from using it, have been demonstrated in numerous studies conducted over the past 30 years. Among the most commonly cited outcomes are:

Source: U.S. Department of Health and Human Services, Medication Assisted Treatment for the 21st Century

Heroin vs. Methadone vs. Suboxone

TOPIC HEROIN METHADONE BUPRENORPHINE (Suboxone)
Onset of action A few seconds 30 minutes 30-40 minutes
Duration of action 4-6 hours 24-36 hours About 24-48 hours
Route of administration Injection, snorting, smoking Oral Sublingual
Frequency of administration Several times a day Daily or more frequently as needed Every day or every other day
Effective dose Ever increasing Blocking dose usually 80-120mg 2-32mg
Tolerance Increasing tolerance Tolerance is stable Tolerance is stable
Euphoric effects Euphoria for up to 2 hours No euphoria when stabilized No euphoria when stabilized
Overdose potential High and increasing Rare (potential is mixed with other depressants) Very rare
Overall safety Potentially lethal Very safe Overall good. Suboxone injection will cause serious withdrawal symptoms in dependant person. Not recommended for pregnancy and caution with liver disease
Withdrawal Within 3-4 hours after last dose Within 24-36 hours after last dose Within 36-48 hours after last dose
Craving Recurring Eliminated with adequate dose Craving may not be totally eliminated due to ceiling effect
Pregnancy/Nursing Grave risk for mother and fetus Safe during pregnancy Not indicated/study underway
Experience of pain and emotions Blunted Normal and full range of emotions Normal pain but opioid analgesics may not be effective – may need to switch to methadone. Full range of emotions
Mood Constant mood swings Normal Normal
Reaction time and intellectual functioning Impaired Reaction time normal. Intellectual functioning unimpaired on stable dose Reaction time presumed to be normal like methadone. FDA cautions driving/operating machinery in the beginning of treatment
HIV & Hepatitis C transmission High rate with needle use and unprotected sex Reduced/eliminated Reduced/eliminated
Immune system for HIV positive persons Rapid progression to AIDS Progrssion slowed Progression presumed same as methadone – data not available
Immune/endocrine system functioning Impaired Normalized during treatment Presumed normalized. Data not available
Stress Response Suppressed Normaized during treatment Normalized during treatment
Criminal activity High level Reduced/eliminated Reduced/eliminated
Community impact Destructing impact. High crime, high death rate, transmission of disease Contributed to public safety, low mortality, increased health Contributed to public safety, low mortality, increased health

Reproduced from 2003 Medication Assisted Treatment for the 21st Century: Community Education Kit, SAMHSA

Frequently Asked Questions

 

Does methadone treatment impair mental function?

Methadone treatment has no adverse effects on intelligence, mental capability or employability. Methadone treated patients are comparable to non-patients in reaction time, in ability to learn, focus and make complex judgements. Methadone treated patients do well in a wide array of vocational endeavors, including professional positions, service occupations and skilled, technical and support jobs.

How is success in methadone and other pharmacotherapy treatments defined?

The primary goals are to help addicts cease heroin use and lead more stable, productive lives. But, as knowledge about heroin addiction and effective treatment practices has grown, so too have the objectives of most methadone treatment programs, which also aim to:

Why do drug-addicted persons keep using drugs?

Nearly all addicted individuals believe at the outset that they can stop using drugs on their own and most try to stop without treatment. Although some people are successful, many attempts result in failure  to  achieve long­term abstinence. Research has shown that long-term drug abuse results in changes in the  brain that persist long after a person stops using drugs. These drug-induced changes in brain function can have many behavioral consequences including an inability to exert control over the impulse to use drugs despite adverse consequences – the defining characteristic of addiction.

How effective is drug addiction treatment?

In addition to stopping drug abuse, the goal of treatment is to return people to productive functioning in the family, workplace, and community . According to research that tracks individuals in treatment over extended periods, most people who get into and remain in treatment stop using drugs, decrease their criminal activity, and improve their occupational, social, and psychological functioning. For example, methadone treatment has been shown to increase participation in behavioral therapy and decrease both drug use and criminal behavior. However, individual treatment outcomes depend on the extent and nature of the patient’s problems, the appropriateness of treatment, and related services used to address those problems and the quality of interaction between the patient and his or her treatment providers.

How long does drug addiction treatment usually last?

Individuals progress through drug addiction treatment at various rates, so there is no predetermined length of treatment. However, research has shown unequivocally that good outcomes are contingent on adequate treatment length. Generally, for residential or outpatient treatment, participation for less than 90 days is of limited effectiveness, and treatment lasting significantly longer is recommended for maintaining positive outcomes. For methadone maintenance, 12 months is considered the minimum and some opioid addicted individuals continue to benefit from methadone maintenance for many years.

How do other mental disorders coexisting with drug addiction affect drug addiction treatment?

Drug addiction is a disease of the brain that frequently occurs with other mental disorders. In fact, as many as 6 in 10 people with an illicit substance use disorder also suffer from another mental illness; and rates are similar for users of licit drugs-i.e., tobacco and alcohol. For these individuals, one condition becomes more difficult to treat successfully as an additional condition is intertwined.

Is the use of a medication like methadone simply replacing one drug addiction with another?

No – as used in maintenance treatment, methadone is not a heroin/opioid substitute. It is prescribed or administered under monitored, controlled conditions and is safe and effective for treating opioid addiction when used as directed.

Source: NIDA, “Principles of Drug Addiction Treatment”

 

 

 

Address and Contact

620 Eighth Avenue
Terre Haute, IN 47804
(800) 742-0787

Programs & Education

Mental Health Screenings

Screenings are a quick way to determine if you or someone you care about may need to reach out to a doctor or mental health professional for evaluation.
Take Screening